XTL Biopharmaceuticals Ltd. (ADR)

General ticker "XTLB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $7.9M (TTM average)

XTL Biopharmaceuticals Ltd. (ADR) does not follow the US Stock Market performance with the rate: -3.1%.

Estimated limits based on current volatility of 4.1%: low 0.82$, high 0.89$

Factors to consider:

  • Total employees count: 42 as of 2005
  • Current price 22.7% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.13$, 2.77$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.94$, 2.40$]

Financial Metrics affecting the XTLB estimates:

  • Positive: with PPE of -12.8 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -13.45 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of -3.84 <= -0.75
  • Positive: Shareholder equity ratio, % of 63.57 > 63.39
  • Negative: 0.01 < Interest expense per share per price, % of 0.71

Similar symbols

Short-term XTLB quotes

Long-term XTLB plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.45MM
Operating Expenses $0.88MM $0.77MM $2.62MM
Operating Income $-0.88MM $-0.77MM $-2.17MM
Non-Operating Income $-0.47MM $-1.02MM $1.01MM
Interest Expense $0.01MM $0.00MM $0.09MM
R&D Expense $0.03MM $0.03MM $0.10MM
Income(Loss) $-1.35MM $-1.78MM $-1.16MM
Taxes $0.00MM $-0.00MM $-0.13MM
Profit(Loss)* $-1.35MM $-0.00MM $-1.03MM
Stockholders Equity $4.00MM $2.22MM $5.43MM
Assets $4.19MM $2.43MM $8.55MM
Operating Cash Flow $-0.90MM $-0.71MM $-1.62MM
Capital expenditure $0.00MM $0.00MM $0.05MM
Investing Cash Flow $0.04MM $0.04MM $-0.84MM
Financing Cash Flow $0.00MM $0.00MM $1.45MM
Earnings Per Share** $-0.25 $-0.00 $-0.15
Ordinary share to ADR 0.01x 0.01x 0.01x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.